Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFTIFINE vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFTIFINE vs NALMEFENE: Safety Overview

Metric NAFTIFINE NALMEFENE
Total FAERS Reports 121 197
Deaths Reported 0 77
Death Rate N/A 39.1%
Hospitalizations 5 118
Average Patient Age 59.7 yrs 44.2 yrs
% Female Patients 55.5% 39.3%
FDA Approval Date Apr 10, 2017 Apr 17, 1995
Manufacturer Sun Pharmaceutical Industries, Inc. Purdue Pharma L.P.
Route TOPICAL INTRAMUSCULAR
Marketing Status Prescription Discontinued